RIBOCICLIB
Clinical trials for RIBOCICLIB explained in plain language.
Never miss a new study
Get alerted when new RIBOCICLIB trials appear
Sign up with your email to follow new studies for RIBOCICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach aims to keep breast cancer treatment on track by protecting blood cells
Disease control Not yet recruitingThis study is testing whether a drug called leucogen can prevent a serious side effect of breast cancer treatment. Researchers want to see if leucogen reduces severe drops in white blood cells (neutropenia) in early-stage breast cancer patients taking ribociclib with hormone ther…
Matched conditions: RIBOCICLIB
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Why do cancer patients quit Life-Saving drugs? new study investigates
Disease control Not yet recruitingThis study aims to understand why patients with early-stage, high-risk breast cancer stop taking their powerful new combination medications too soon. Researchers will follow 81 patients who are prescribed a standard hormone therapy pill plus a newer drug (like abemaciclib or ribo…
Matched conditions: RIBOCICLIB
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC